Trial · NCT01555697
Participant flow48
How many started, completed or left each group, period by period.
1 to 20 of 48
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Memantine | 10 | |
| Overall Study | STARTED | Healthy Subjects: Placebo 1st, Then 10 mg Memantine | 10 | |
| Overall Study | STARTED | Subjects With Schizophrenia: 10 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | STARTED | Healthy Subjects: 10 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | STARTED | Subjects With Schizophrenia: Placebo 1st, Then 20 mg Memantine | 10 | |
| Overall Study | STARTED | Healthy Subjects: Placebo 1st, Then 20 mg Memantine | 10 | |
| Overall Study | STARTED | Subjects With Schizophrenia: 20 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | STARTED | Healthy Subjects: 20 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Memantine | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Healthy Subjects: Placebo 1st, Then 10 mg Memantine | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Subjects With Schizophrenia: 10 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Healthy Subjects: 10 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Subjects With Schizophrenia: Placebo 1st, Then 20 mg Memantine | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Healthy Subjects: Placebo 1st, Then 20 mg Memantine | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Subjects With Schizophrenia: 20 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | 6 Hours Lab Testing Day 1 | Healthy Subjects: 20 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | Approx 7 Day Washout | Subjects With Schizophrenia: Placebo 1st, Then 10 mg Memantine | 10 | |
| Overall Study | Approx 7 Day Washout | Healthy Subjects: Placebo 1st, Then 10 mg Memantine | 10 | |
| Overall Study | Approx 7 Day Washout | Subjects With Schizophrenia: 10 mg Memantine 1st, Then Placebo | 10 | |
| Overall Study | Approx 7 Day Washout | Healthy Subjects: 10 mg Memantine 1st, Then Placebo | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01555697/flow